Extended release formulation of divalproex sodium

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 9/22 (2006.01) A61K 9/20 (2006.01) A61K 31/19 (2006.01) A61P 25/06 (2006.01) A61P 25/08 (2006.01)

Patent

CA 2488691

The present invention relates to an extended release pharmaceutical composition comprising valproic acid, a pharmaceutically acceptable salt, ester, or amide thereof or divalproex sodium.

L'invention concerne une composition pharmaceutique à libération prolongée qui comprend de l'acide valproïque, un sel, un ester ou un amide pharmaceutiquement acceptables de cet acide ou du divalproex de sodium.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Extended release formulation of divalproex sodium does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Extended release formulation of divalproex sodium, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Extended release formulation of divalproex sodium will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1576829

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.